相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transcriptional regulation of SPROUTY2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3
M. Clarke et al.
LEUKEMIA (2017)
miR-330-5p suppresses glioblastoma cell proliferation and invasiveness through targeting ITGA5
Linsen Feng et al.
BIOSCIENCE REPORTS (2017)
Roles of microRNA-330 and Its Target Gene ING4 in the Development of Aggressive Phenotype in Hepatocellular Carcinoma Cells
Xiao Hu et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL
Ashima Shukla et al.
BLOOD (2016)
MicroRNA-330-5p negatively regulates ITGA5 expression in human colorectal cancer
Hye-In Yoo et al.
ONCOLOGY REPORTS (2016)
Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells
Solange Trehoux et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
Seyedmehdi Shojaee et al.
CANCER CELL (2015)
Alike but Different: RAF Paralogs and Their Signaling Outputs
Enrico Desideri et al.
CELL (2015)
The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles of effective cancer therapy
Zutao Yu et al.
FUTURE MEDICINAL CHEMISTRY (2015)
MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma
Feng Fang et al.
JOURNAL OF HEPATOLOGY (2015)
MicroRNA-331-3p Promotes Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting PH Domain and Leucine-Rich Repeat Protein Phosphatase
Rui-Min Chang et al.
HEPATOLOGY (2014)
Sprouty-2 regulates HIV-specific T cell polyfunctionality
Yen-Ling Chiu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Targeting RAS-ERK signalling in cancer: promises and challenges
Ahmed A. Samatar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Tumor Size Does Not Independently Affect Long-Term Survival after Curative Resection of Solitary Hepatocellular Carcinoma Without Macroscopic Vascular Invasion
Han Zhang et al.
WORLD JOURNAL OF SURGERY (2014)
Above 5 cm, Size Does Not Matter Anymore in Patients with Hepatocellular Carcinoma
Chetana Lim et al.
WORLD JOURNAL OF SURGERY (2014)
miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42
Yuefeng Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
MicroRNAs: New Tools for Diagnosis, Prognosis, and Therapy in Hepatocellular Carcinoma?
Silvia Giordano et al.
HEPATOLOGY (2013)
MicroRNA-140-5p Suppresses Tumor Growth and Metastasis by Targeting Transforming Growth Factor β Receptor 1 and Fibroblast Growth Factor 9 in Hepatocellular Carcinoma
Hao Yang et al.
HEPATOLOGY (2013)
Overexpression of Forkhead Box C1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma
Limin Xia et al.
HEPATOLOGY (2013)
Long-term Outcome after Liver Resection for Hepatocellular Carcinoma Larger than 10 cm
Pierre Allemann et al.
WORLD JOURNAL OF SURGERY (2013)
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
Douglas G. Altman et al.
BMC MEDICINE (2012)
Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
Piro Lito et al.
CANCER CELL (2012)
Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways
Chunmei Wang et al.
JOURNAL OF HEPATOLOGY (2012)
Sprouty2 controls proliferation of palate mesenchymal cells via fibroblast growth factor signaling
Kaori Matsumura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Solitary Large Hepatocellular Carcinoma A Specific Subtype of Hepatocellular Carcinoma With Good Outcome After Hepatic Resection
Lian-Yue Yang et al.
ANNALS OF SURGERY (2009)
MicroRNAs and Cancer: Short RNAs Go a Long Way
Andrea Ventura et al.
CELL (2009)
Novel Role for Epidermal Growth Factor-Like Domain 7 in Metastasis of Human Hepatocellular Carcinoma
Fan Wu et al.
HEPATOLOGY (2009)
MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation
K-H Lee et al.
ONCOGENE (2009)
Sprouty proteins, masterminds of receptor tyrosine kinase signaling
Miguel A. Cabrita et al.
ANGIOGENESIS (2008)
Inhibition of Invasion and Metastasis of Hepatocellular Carcinoma Cells via Targeting RhoC In vitro and In vivo
Wei Wang et al.
CLINICAL CANCER RESEARCH (2008)
Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomas
A. Sanchez et al.
ONCOGENE (2008)
Large hepatocellular carcinoma: Time to stop preoperative biopsy
Alastair L. Young et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma
CW Fong et al.
CANCER RESEARCH (2006)
SPRY2 is an inhibitor of the Ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant
D Tsavachidou et al.
CANCER RESEARCH (2004)
Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
W Wang et al.
BRITISH JOURNAL OF CANCER (2004)
分享论文
